Bong Go pushes for cheaper meds to complement UHC

February 17, 2020
Bong Go. & Rodrigo Duterte

SENATOR Christopher “Bong” Go reiterated his commitment to push for measures to provide all Filipinos with better access to affordable essential medicines.

He expressed this as President Rodrigo Duterte signed Executive Order (EO) No. 104 dated February 17, 2020, which regulates the prices of select drugs including essential medicines most commonly prescribed to patients.  

“Nagpapasalamat po ako sa ating mahal na Pangulo sa pag-apruba ng rekomendasyon ng Senado na paigtingin pa lalo ang access ng mga Pilipino sa murang gamot. Patuloy po tayong magtatrabaho para maging mas mabilis, maayos at maaasahan ang serbisyong pang-medikal sa ating bansa,” Go said.  

“Sa mga polisiya na aking hinahain o sinusuportahan, palagi ko pong uunahin ang kapakanan ng bawat Pilipino,” he added.

The EO was signed a few months after Go, the Chair of the Senate Committee on Health and Demography, vowed to personally discuss the matter with the President.

At the Senate session on November 5, Go stated that he would “suggest to the President the inclusion of all essential medicines in the proposed list of expanded MDRP (Maximum Drug Retail Prices) and for its immediate release to complement the Universal Health Care Law.”

On January 13, the senator reiterated in a radio interview his support for the proposed policy. “Ako naman po ay nakikiusap sa mga kompanya, balansehin po natin ‘yung profit at saka kapakanan po at interes po ng bawat Pilipino at bawat pasyente,” he said.  

EO No. 104 imposes Maximum Retail Price (MRP) and Maximum Wholesale Price (MWP) on “select drugs and medicines totaling to 86 drug molecules or 133 drug formulas” annexed to the order.

The EO also orders representatives from the Department of Health (DOH) and the Department of Trade and Industry (DTI) to “convene and review” the prices of the remaining 36 drug molecules or 72 drug formulas previously proposed to be included in the MRP and MWP list.

The President signed the EO, as recommended by DOH and echoed by various senators including Go, in accordance with the provisions of Republic Act (RA) No. 9502 or the Cheaper Medicines Act of 2008, which grants the President of the Philippines the power to impose maximum retail prices over drugs and medicines sold in the country, upon the recommendation of the DOH Secretary.

“Healthcare is a right, not a commodity,” Go regularly emphasizes in his statements. He also said that he is supporting the initiative to control the prices of select drugs and medicine as “an advocate of universal healthcare access for all Filipinos” and “to ensure that our countrymen and women gain easier access to cheaper quality medicines.”

He added, “Essential medicines in the Philippines continue to be exorbitantly priced relative to international counterparts. Generic drug prices are also approximately up to four times higher than international reference prices.”

The EO further states that the MRP will be imposed on all public and private retail outlets, including drugstores, hospitals and hospital pharmacies, health maintenance organizations, convenience stores and supermarkets and the like.

MWP, meanwhile, will be imposed on all manufacturers, wholesalers, traders, distributors and the like.

The drugs and medicines included in the MRP and MWP list will be subject to review by the DOH, in consultation with the DTI, within six months from the effectivity of the order and every six months thereafter.

Violations of EO No. 104 will be dealt with in accordance with RA 9502 and other related laws.